Cav3.1 Antibody: FITC

Calcium channel CaV3.1 (a1G) is a low-voltage-activated T-type calcium channel. Such T-type channels are expressed throughout the body. In the heart, they may be involved in pacemaker current. In neurons, these channels may play a secondary pacemaker role (1). With the ubiquitous expression, it is not surprising that alterations in channel function have been implicated in disease. Drugs that act to block T-type calcium channels are used as anti-hypertensives, antiepileptic's, and blocking of T-type calcium channels may be involved in the action of some anesthetics and antipsychotics as well (1). Much remains to be determined about the precise cellular localization, in vivo physiological roles, roles in disease states and possible routes to modulate their structure/function to ameliorate effects of disease.

CACNA1G Antibody, CaV T1 Antibody, Cav3 1 Antibody, cav3 1c Antibody, KIAA1123 Antibody, MGC117234 Antibody, NBR13 Antibody, voltage gated calcium channel cav3.1 Antibody, calcium channel voltage dependent alpha 1G subunit Antibody, calcium channel voltage dependent T type alpha 1G subunit Antibody, calcium channel voltage dependent T type alpha1G subunit Antibody, voltage dependent calcium channel alpha 1G subunit isoform 11 Antibody, voltage dependent T type calcium channel subunit alpha 1G Antibody, Voltage gated calcium channel subunit alpha Cav3 1 Antibody

1 µg/ml of SMC-405 was sufficient for detection of Cav3.1 in 20 µg of rat brain membrane lysate and assayed by colorimetric immunoblot analysis using goat anti-mouse IgG:HRP as the secondary antibody.